66 related articles for article (PubMed ID: 1641820)
1. Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial.
Bounameaux H; Banga JD; Bluhmki E; Coccheri S; Fiessinger JN; Haarmann W; Lockner D; Mahler F; Ninet J; Schneider PA
Thromb Haemost; 1992 Mar; 67(3):306-9. PubMed ID: 1641820
[TBL] [Abstract][Full Text] [Related]
2. An exploratory trial of two dosages of a novel synthetic thrombin inhibitor (napsagatran, Ro 46-6240) compared with unfractionated heparin for treatment of proximal deep-vein thrombosis -- results of the European multicenter ADVENT trial.
Bounameaux H; Ehringer H; Hulting J; Rasche H; Rapold HJ; Zultak M
Thromb Haemost; 1997 Sep; 78(3):997-1002. PubMed ID: 9308743
[TBL] [Abstract][Full Text] [Related]
3. Intermittent regional therapy with rt-PA is not superior to systemic thrombolysis in deep vein thrombosis (DVT)--a German multicenter trial.
Schwieder G; Grimm W; Siemens HJ; Flor B; Hilden A; Gmelin E; Friedrich HJ; Wagner T
Thromb Haemost; 1995 Nov; 74(5):1240-3. PubMed ID: 8607102
[TBL] [Abstract][Full Text] [Related]
4. Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis.
Marder VJ; Brenner B; Totterman S; Francis CW; Rubin R; Rao AK; Kessler CM; Kwaan HC; Sharma GV; Fong KL
J Lab Clin Med; 1992 May; 119(5):485-95. PubMed ID: 1583404
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
[TBL] [Abstract][Full Text] [Related]
6. [Continuous intravenous infusion versus intermittent administration of streptokinase in patients with deep venous thrombosis of the lower extremity].
Lopaciuk S; Meissner AJ; Ziemski JM; Tokarz A; Psuja P; Zawilska K; Głowiński S; Wołczyński Z; Czestochowska E; Tymiński W
Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):704-7. PubMed ID: 1669137
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic therapy of deep vein thrombosis with continuous intravenous infusion of a recombinant tissue plasminogen activator.
Zimmerman R; Gürsoy A; Horn A; Harenberg J; Diehm C; Kübler W
Semin Thromb Hemost; 1991 Jan; 17(1):48-54. PubMed ID: 1904629
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis--a randomized clinical trial.
Pini M; Pattachini C; Quintavalla R; Poli T; Megha A; Tagliaferri A; Manotti C; Dettori AG
Thromb Haemost; 1990 Oct; 64(2):222-6. PubMed ID: 2270531
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
[TBL] [Abstract][Full Text] [Related]
10. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
[TBL] [Abstract][Full Text] [Related]
11. [Thrombolytic therapy of deep venous thrombosis with rt-PA].
Zimmermann R; Horn A; Harenberg J; Diehm C; Müller-Bühl U; Kübler W
Klin Wochenschr; 1988; 66 Suppl 12():137-42. PubMed ID: 3126342
[TBL] [Abstract][Full Text] [Related]
12. [Randomized double-blind study comparing tissue-type plasminogen activator with placebo in acute myocardial infarct].
Bleifeld W; Verstraete M; Brower RW; Collen D; Dunning AJ; Lubsen J; Michel PL; Schofer J; Vanhaecke J; Van de Werf F
Klin Wochenschr; 1988; 66 Suppl 12():86-92. PubMed ID: 3126349
[TBL] [Abstract][Full Text] [Related]
13. [Acute thrombosis of the portal system. Treatment with alteplase and heparin or with heparin alone in 10 patients].
Lagasse JP; Bahallah ML; Salem N; Debillon G; Labarrière D; Serve MP; Advenier V; Causse X; Legoux JL
Gastroenterol Clin Biol; 1997; 21(12):919-23. PubMed ID: 9587554
[TBL] [Abstract][Full Text] [Related]
14. Studies on the medical treatment of deep vein thrombosis.
Schulman S
Acta Med Scand Suppl; 1985; 704():1-68. PubMed ID: 3913282
[TBL] [Abstract][Full Text] [Related]
15. Catheter directed thrombolysis for treatment of ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency.
Sillesen H; Just S; Jørgensen M; Baekgaard N
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):556-62. PubMed ID: 16125983
[TBL] [Abstract][Full Text] [Related]
16. [Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in 13 children: a case series].
Schermer E; Streif W; Genser N; Frühwirth M; Trawöger R; Simma B
Wien Klin Wochenschr; 2000 Nov; 112(21):927-33. PubMed ID: 11144008
[TBL] [Abstract][Full Text] [Related]
17. [The treatment of deep venous thrombosis. Thrombolysis vs heparin].
Schmutzler R
Phlebologie; 1990; 43(4):656-65; discussion 666. PubMed ID: 2093922
[TBL] [Abstract][Full Text] [Related]
18. [Thrombolysis with rt-PA in children with arterial and venous thromboses--a new therapy concept].
Nowak-Göttl U; Kreuz WD; Schwabe D; Linde R; Kornhuber B
Klin Padiatr; 1991; 203(5):359-62. PubMed ID: 1942942
[TBL] [Abstract][Full Text] [Related]
19. Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis.
Verhaeghe R; Besse P; Bounameaux H; Marbet GA
Thromb Res; 1989 Jul; 55(1):5-11. PubMed ID: 2506661
[TBL] [Abstract][Full Text] [Related]
20. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
